Global 3D Printed Drugs Market Size study, by Technology (Inkjet Printing, Zipdose Technology, Stereolithography, Fused Deposition Modeling), By Application (Orthopedic, Neurology, Dental, Others), By End-use (Hospitals & clinics, Research Laboratories, O

Global 3D Printed Drugs Market Size study, by Technology (Inkjet Printing, Zipdose Technology, Stereolithography, Fused Deposition Modeling), By Application (Orthopedic, Neurology, Dental, Others), By End-use (Hospitals & clinics, Research Laboratories, Others) and Regional Forecasts 2022-2028

Global 3D Printed Drugs Market is valued at approximately USD 72.02 million in 2021 and is anticipated to grow with a healthy growth rate of more than 15.30% over the forecast period 2022-2028. 3D printed drugs are prescriptions created with the 3D printing process to provide individuals with safe and effective tailored medications. These drugs don't need to be swallowed whole because of the unitary porous architecture that makes it simple for them to scatter in the mouth. It makes it simple for producers to alter the size, shape, appearance, and rate of distribution of a variety of medications. The market is booming as a result of rising demand for personalized drugs and rapidly expanding R&D activities supporting 3D printing. By producing personalized medical therapies, this technology creates promising opportunities for improving patient care. To make pharmaceuticals safer and more effective, pharmaceutical research companies have also been looking into the development of more specialised remedies since the establishment of the United States Personalized Medicine Initiative in 2015. As a result, demand for 3D-printed drugs is expected to increase in the coming years.Increased investments by operating players in the production of advanced and effective 3D printed pharmaceuticals, as well as breakthroughs in 3D printing technology, are expected to drive market growth over the forecast period. CurfiyLabs and Natural Machines, for example, collaborated in March 2022 on the production of these medicines based on the needs of individual patients. This is expected to allow pharmacies and hospitals to receive medications more quickly. However, the adverse effects of these drugs, the development of illicit drugs using 3D printing and the absence of government restrictions for 3D printed goods are two factors that are limiting market expansion. On the other hand, growing public knowledge of the advantages of these medications, such as their rapid solubility, along with breakthroughs in healthcare systems and technology in emerging nations, are anticipated to create a wide range of potential for market expansion.

The key regions considered for the global 3D Printed Drugs market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific has the largest market share in the 3D printed drugs market and is expected to grow at a healthy CAGR during the forecast period. Rapid development of healthcare infrastructure and increased investment in healthcare research and development are expected to drive the growth of the Asia Pacific 3D printed drugs market. The Europe region is also expected to grow satisfactorily during the forecast period, owing to rising health consciousness among Europeans.

Major market players included in this report are:
Extend Biosciences
BioDuro
Affinity Therapeutics
Osmotica Pharmaceuticals
Aprecia Pharmaceuticals LLC
GlaxoSmithKline Plc
FabRx Ltd
Hewlett Packard Caribe
Merck
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
ByTechnology:
Inkjet Printing
Fused Deposition Modeling
Stereolithography
ZipDose Technology

By Application:
Orthopedic
Neurology
Dental
Others
By End-use:
Hospitals & clinics
Research Laboratories
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global 3D Printed Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Extend Biosciences
BioDuro
Affinity Therapeutics
Osmotica Pharmaceuticals
Aprecia Pharmaceuticals LLC
GlaxoSmithKline Plc
FabRx Ltd
Hewlett Packard Caribe
Merck

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.